Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. It offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers. The company was founded in 2020 and is headquartered in Hohhot, China.
Stock data | 2023 | Change |
---|---|---|
Price | $5.86 | N/A |
Market Cap | $175.91M | N/A |
Shares Outstanding | 30.02M | 0.06% |
Employees | 65.00 | N/A |
Shareholder Equity | -570.65K | -44.18% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -5860.00 | N/A |
P/S Ratio | 46.07 | N/A |
P/B Ratio | -308.25 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.0369 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $3.82M | N/A |
Earnings | $21.09K | N/A |
EPS | -0.001 | N/A |
Earnings Yield | -0.0002 | N/A |
Gross Margin | 0.845 | N/A |
Operating Margin | 0.0077 | N/A |
Net income margin | 0.0055 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $1.48M | N/A |
Total Debt | $13.47K | N/A |
Cash on Hand | $1.14M | N/A |
Debt to Equity | -3.5984 | 125.28% |
Cash to Debt | $84.38 | 4187.73% |
Current Ratio | 0.6415 | 146.41% |